These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1219 related items for PubMed ID: 25558667

  • 1. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N, Pehlivanov B, Orbecova M, Uchikova E, Ivancheva H.
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [Abstract] [Full Text] [Related]

  • 2. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 3. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [Abstract] [Full Text] [Related]

  • 4. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A, Robin G, Pigny P, Lefebvre T, Catteau-Jonard S, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1716-1722. PubMed ID: 28854589
    [Abstract] [Full Text] [Related]

  • 5. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, Cohen A, Hougaard DM, Nyboe Andersen A.
    Hum Reprod; 2014 Apr 01; 29(4):791-801. PubMed ID: 24435776
    [Abstract] [Full Text] [Related]

  • 6. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A, Peigné M, Grynberg M, Arouche N, Taieb J, Hesters L, Gonzalès J, Picard JY, Dewailly D, Fanchin R, Catteau-Jonard S, di Clemente N.
    Hum Reprod; 2013 Mar 01; 28(3):762-9. PubMed ID: 23321213
    [Abstract] [Full Text] [Related]

  • 7. Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome.
    Sahmay S, Atakul N, Oncul M, Tuten A, Aydogan B, Seyisoglu H.
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep 01; 170(1):157-61. PubMed ID: 23806449
    [Abstract] [Full Text] [Related]

  • 8. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D, Alebić MŠ, Duhamel A, Stojanović N.
    Hum Reprod; 2014 Nov 01; 29(11):2536-43. PubMed ID: 25267785
    [Abstract] [Full Text] [Related]

  • 9. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S, Laven JSE, Duhamel A, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1723-1731. PubMed ID: 28854584
    [Abstract] [Full Text] [Related]

  • 10. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ, Stojanović N, Duhamel A, Dewailly D.
    Hum Reprod; 2015 Aug 01; 30(8):1927-33. PubMed ID: 26048913
    [Abstract] [Full Text] [Related]

  • 11. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S, Atakul N, Aydogan B, Aydin Y, Imamoglu M, Seyisoglu H.
    Acta Obstet Gynecol Scand; 2013 Dec 01; 92(12):1369-74. PubMed ID: 23980726
    [Abstract] [Full Text] [Related]

  • 12. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
    Li J, Li R, Yu H, Zhao S, Yu Y, Qiao J.
    Syst Biol Reprod Med; 2015 Apr 01; 61(2):103-9. PubMed ID: 25329139
    [Abstract] [Full Text] [Related]

  • 13. Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria.
    Jamil AS, Alalaf SK, Al-Tawil NG, Al-Shawaf T.
    Arch Gynecol Obstet; 2016 Feb 01; 293(2):447-56. PubMed ID: 26408006
    [Abstract] [Full Text] [Related]

  • 14. Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome.
    Catteau-Jonard S, Pigny P, Reyss AC, Decanter C, Poncelet E, Dewailly D.
    J Clin Endocrinol Metab; 2007 Nov 01; 92(11):4138-43. PubMed ID: 17698904
    [Abstract] [Full Text] [Related]

  • 15. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.
    Tal R, Seifer DB, Khanimov M, Malter HE, Grazi RV, Leader B.
    Am J Obstet Gynecol; 2014 Jul 01; 211(1):59.e1-8. PubMed ID: 24593938
    [Abstract] [Full Text] [Related]

  • 16. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.
    Wachs DS, Coffler MS, Malcom PJ, Chang RJ.
    J Clin Endocrinol Metab; 2007 May 01; 92(5):1871-4. PubMed ID: 17299061
    [Abstract] [Full Text] [Related]

  • 17. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
    Bhide P, Dilgil M, Gudi A, Shah A, Akwaa C, Homburg R.
    Fertil Steril; 2015 Feb 01; 103(2):537-41. PubMed ID: 25467043
    [Abstract] [Full Text] [Related]

  • 18. Anti-mullerian hormone as a predictive factor in assisted reproductive technique of polycystic ovary syndrome patients.
    Aleyasin A, Aghahoseini M, Mokhtar S, Fallahi P.
    Acta Med Iran; 2011 Feb 01; 49(11):715-20. PubMed ID: 22131240
    [Abstract] [Full Text] [Related]

  • 19. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T, Panichyawat N, Indhavivadhana S, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, Pratumvinit B, Sa-Nga-Areekul N.
    Taiwan J Obstet Gynecol; 2018 Aug 01; 57(4):499-506. PubMed ID: 30122568
    [Abstract] [Full Text] [Related]

  • 20. The role of serum anti-Müllerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome.
    Casadei L, Madrigale A, Puca F, Manicuti C, Emidi E, Piccione E, Dewailly D.
    Gynecol Endocrinol; 2013 Jun 01; 29(6):545-50. PubMed ID: 23506275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.